Bill & Melinda Gates Foundation Announces New Commitments For Vaccine Candidates With The Potential To Reduce Newborn And Infant Deaths In Lower-Income Countries
September 29, 2022
September 29, 2022
SEATTLE, Washington, Sept. 29 (TNSres) -- The Bill and Melinda Gates Foundation issued the following news release:
The Bill & Melinda Gates Foundation announced grants totaling nearly US$128 million to support the development and accessibility of maternal vaccines for Group B Streptococcus (GBS) and Respiratory Syncytial Virus (RSV), two of the leading causes of death for newborns and young infants in lower-income countries.
No vaccines currently exist for these inf . . .
The Bill & Melinda Gates Foundation announced grants totaling nearly US$128 million to support the development and accessibility of maternal vaccines for Group B Streptococcus (GBS) and Respiratory Syncytial Virus (RSV), two of the leading causes of death for newborns and young infants in lower-income countries.
No vaccines currently exist for these inf . . .